We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Efficiency and Workflow Enhanced in Today’s Laboratories

By Christina Chang, LabMedica Regional Director
Posted on 15 Jul 2013
AACC 2012: Solutions being offered include informatics, and processes to streamline operations and enhance workflow to produce faster and more accurate results.

The new solutions to improve data management and automation are being highlighted at this year’s American Association for Clinical Chemistry Lab Expo (AACC) annual meeting, July 15-19, in Los Angeles (CA, USA). More...


OneLab is an integrated Web-based software platform that manages data flowing through the lab. It is being showcased by Abbott (Abbott Park, IL, USA). OneLab is currently available in select countries.

Abbott will also showcase Accelerator a3600 and p540, two of the latest automation solutions, which help labs to improve efficiency and workflow. All of these solutions will be available to labs across the United States in the coming months, but attendees are getting a preview at the AACC 2012 meeting.

Additionally, Abbott is featuring its expansive molecular diagnostic and point-of-care (POC) offerings. The Abbott m2000, an automated system that integrates sample preparation and extraction with real-time polymerase chain reaction (PCR) amplification and detection technology, will be demonstrated at the Expo.

Abbott will also demonstrate five new advanced quality features on its leading i-STAT handheld blood analyzer, designed to help hospitals better manage their point-of-care testing programs and support compliance with changing laboratory regulations.

Twenty-three scientific posters and oral presentations are being presented by Abbott in the AACC scientific program. Some posters cover cardiac markers, such as troponin and galectin-3, whereas others focus on the performance of several clinical chemistry assays as well as on important disease states, such as transplant, endocrine, metabolic, and congenitals.

Related Links:

Abbott




New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Urine Analyzer
respons® UDS100
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The AidaBREAST assay integrates multimodal data to provide patient-specific 10-year recurrence risk and individualized predictions of radiation therapy benefit (photo courtesy of PreludeDx)

Multi-Omic Assay Predicts Recurrence and Radiation Benefit in Early Breast Cancer

Early-stage invasive breast cancer is frequently managed with breast-conserving surgery followed by adjuvant radiation therapy, but the magnitude of benefit from radiation varies among patients.... Read more

Pathology

view channel
Image: The researchers derived a gene-based signature and a blood test to help identify this high-risk subgroup (photo credit: Shutterstock)

New Tissue Mapping Approach Identifies High-Risk Form of Diabetic Kidney Disease

Diabetic kidney disease is a leading cause of chronic kidney disease and end-stage kidney disease, affecting 20%–40% of people with diabetes and more than 107 million individuals worldwide as of 2021.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.